NCT07392970 2026-04-09Motixafortide for MRD Sensitization in AMLWashington University School of MedicinePhase 2 Not yet recruiting10 enrolled
NCT07517705 2026-04-08MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell LymphomaUniversity of NebraskaPhase NA Not yet recruiting50 enrolled